Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Fujifilm acquires Wako

by Jean-François Tremblay
April 17, 2017 | A version of this story appeared in Volume 95, Issue 16

Japan’s Fujifilm has acquired Wako Pure Chemical Industries for $1.3 billion and is now creating a fine chemicals division to house its chemical operations. Wako, previously majority-owned by Takeda Pharmaceutical and Nihon Pharmaceutical, supplies about 200,000 lab chemicals and produces diagnostic reagents and fine chemicals used in the life sciences and electronics industries. Fujifilm says the acquisition of Wako will boost its presence in the fine chemicals and life sciences sectors, where by itself or through subsidiaries, it already provides electronic materials, cells used in regenerative medicine (see page 23), and contract manufacturing services. Fujifilm notes that it has long experience in the fine chemicals sector thanks to its roots as a producer of photographic film.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.